Gilteritinib price

Gilteritinib (Gilteritinib) is a drug used to treat certain types of leukemia. It is a tyrosine kinase inhibitor primarily used to treat acute myeloid leukemia (AML, Acute Myeloid Leukemia) in adults with FLT3 (FMS-like tyrosine kinase 3) mutations. FLT3mutations are one of the most common molecular abnormalities in AML and lead to abnormal cell proliferation and progression of leukemia.

The price of foreign original drugs of gilitinib is high. For example, the price of the Hong Kong version of the original drug is around 90,000 yuan, and the European version of the original drug is as high as more than 200,000 yuan, which is simply unaffordable for ordinary patients. But what is gratifying is that there are already foreign generic drugs of giritinib, mainly Laotian generic drugs. The price is about four to five thousand yuan, which is relatively cheap. In terms of drug ingredients, the ingredients of domestic and foreign original gilitinib drugs are basically the same as those of generic drugs.

Giritinib is currently on the market in China, but it is not included in medical insurance. If patients need it, they can go to the hospital to buy it at their own expense, but the price is very high, about 35,000 yuan. For specific prices, please consult the local hospital pharmacy.

Giritinib interferes with the growth and division of leukemia cells by inhibiting the activity ofFLT3kinase. The drug has been approved to treat patients with certain types of AML, particularly those who are positive for the FLT3 mutation.

Please note that the specific use, dosage and treatment regimen of the drug should be determined based on the doctor's prescription and the patient's specific condition, so if you or someone you know needs to use gilitinib or related leukemia treatment, you should consult a medical professional for detailed information and advice. In addition, drug information may be updated over time, so it is recommended to check the latest drug information at any time.